Invesco
NMRD

Invesco’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

Invesco’s Portfolio NMRD Stock Details NMRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-15,163
Closed -$116K – 4058
2021
Q1 		$116K Buy
15,163
+202
+1% +$1.34K ﹤0.01% 3744
2020
Q4 		$56K Buy
+14,961
New +$57.7K ﹤0.01% 3733

Other funds holding NMRD

Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Invesco's NMRD Position: Q2 2021 in Review

Invesco sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q2 2021, closing a stake of 15,163 shares — an estimated $116K sold.

Invesco first reported a position in NMRD in Q4 2020 and held it in 2 quarters. The position peaked at $116K in Q1 2021. 29 funds tracked by Wall St. Rank hold NMRD as of Q2 2021.

  • Invesco reported no remaining Nemaura Medical, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Invesco sold 15,163 Nemaura Medical, Inc. Common Stock shares in Q2 2021, an estimated $116K.
  • Invesco first reported a position in Nemaura Medical, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • Invesco's Nemaura Medical, Inc. Common Stock position peaked at $116K in Q1 2021.
  • 29 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q2 2021.

Based on Invesco's 13F filing for Q2 2021, filed 17 Aug 2021.